GSK3B and chronic kidney disease: Key pathways, including PI3K-Akt, MAPK, and AGE-RAGE signaling, were identified as critical to CKD pathophysiology, with hub proteins such as EGFR, IL-6, and GSK3β validated for their strong binding affinity to dapagliflozin.